Literature DB >> 15504551

Hepatocyte growth factor plays roles in the induction and autocrine maintenance of bone marrow stromal cell IL-11, SDF-1 alpha, and stem cell factor.

Yoshiko Matsuda-Hashii1, Kenji Takai, Hideaki Ohta, Hiroyuki Fujisaki, Sadao Tokimasa, Yuko Osugi, Keiichi Ozono, Kunio Matsumoto, Toshikazu Nakamura, Junichi Hara.   

Abstract

OBJECTIVE: Bone marrow (BM) stroma provides the microenvironment required for long-term hematopoiesis, and this is supported by direct interaction between stromal cells and hematopoietic cells, mediated by adhesion molecules, and through cytokine releases from the BM stroma. In a previous study, we demonstrated that hepatocyte growth factor (HGF) is one of the cytokines constitutively produced from BM stromal cells, promoting hematopoiesis mainly in an indirect way. We also showed that stromal cells themselves express HGF receptor c-MET. It was therefore postulated that HGF exerts its effect on hematopoiesis and maintenance of the hematopoietic microenvironment in a paracrine and autocrine manner.
METHODS: The effect of HGF on stromal cells was analyzed by neutralizing intrinsic HGF.
RESULTS: Addition of neutralizing anti-HGF antibody inhibited the ability of BM stromal cells to support colony formation from CD34(+) cells and reduced production of significant cytokines from stromal cells, interleukin-11 (IL-11), stromal cell-derived factor-1 alpha (SDF-1 alpha), and to a lesser extent, stem cell factor (SCF). Furthermore, this neutralizing antibody reduced proliferation of stromal cells and inhibited adhesion of stromal cells to collagen type IV and fibronectin. Inhibition of adhesion to fibronectin was mediated by inhibition of alpha(5)beta(1)-integrin.
CONCLUSION: These findings indicate that HGF constitutively produced from BM stromal cells is an autocrine regulator, which is able to maintain the hematopoietic microenvironment through stimulating proliferation and adhesion to the extracellular matrix and promoting hematopoiesis through inducing constitutive production of IL-11, SDF-1 alpha, and SCF by stromal cells themselves.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15504551     DOI: 10.1016/j.exphem.2004.06.012

Source DB:  PubMed          Journal:  Exp Hematol        ISSN: 0301-472X            Impact factor:   3.084


  21 in total

1.  Serine protease inhibitor kunitz-type 2 is downregulated in myelodysplastic syndromes and modulates cell-cell adhesion.

Authors:  Fernanda Marconi Roversi; Matheus Rodrigues Lopes; João Agostinho Machado-Neto; Ana Leda F Longhini; Adriana da Silva Santos Duarte; Mariana Ozello Baratti; Bruna Palodetto; Flávia Adolfo Corrocher; Fernando Vieira Pericole; Paula de Melo Campos; Patricia Favaro; Fabiola Traina; Sara Teresinha Olalla Saad
Journal:  Stem Cells Dev       Date:  2014-02-18       Impact factor: 3.272

Review 2.  Cell based therapies for ischemic stroke: from basic science to bedside.

Authors:  Xinfeng Liu; Ruidong Ye; Tao Yan; Shan Ping Yu; Ling Wei; Gelin Xu; Xinying Fan; Yongjun Jiang; R Anne Stetler; George Liu; Jieli Chen
Journal:  Prog Neurobiol       Date:  2013-12-12       Impact factor: 11.685

3.  Bone marrow transcriptome and epigenome profiles of equine common variable immunodeficiency patients unveil block of B lymphocyte differentiation.

Authors:  Rebecca L Tallmadge; Lishuang Shen; Chia T Tseng; Steven C Miller; Jay Barry; M Julia B Felippe
Journal:  Clin Immunol       Date:  2015-05-16       Impact factor: 3.969

4.  Bone marrow-derived mesenchymal stem cells protect against experimental liver fibrosis in rats.

Authors:  Dong-Chang Zhao; Jun-Xia Lei; Rui Chen; Wei-Hua Yu; Xiu-Ming Zhang; Shu-Nong Li; Peng Xiang
Journal:  World J Gastroenterol       Date:  2005-06-14       Impact factor: 5.742

5.  Hepatocyte growth factor promotes proliferation, invasion, and metastasis of myeloid leukemia cells through PI3K-AKT and MAPK/ERK signaling pathway.

Authors:  Jiang-Rui Guo; Wei Li; Yong Wu; Lin-Qing Wu; Xin Li; Ya-Fei Guo; Xiao-Hui Zheng; Xiao-Lan Lian; Hui-Fang Huang; Yuan-Zhong Chen
Journal:  Am J Transl Res       Date:  2016-09-15       Impact factor: 4.060

Review 6.  Therapeutic potential of adult bone marrow stem cells in liver disease and delivery approaches.

Authors:  You Qing Xu; Zun Chang Liu
Journal:  Stem Cell Rev       Date:  2008       Impact factor: 5.739

7.  Bone marrow-derived mesenchymal stem cells effectively regenerate fibrotic liver in bile duct ligation rat model.

Authors:  Hoda E Mohamed; Sahar E Elswefy; Laila A Rashed; Nahla N Younis; Mohamed A Shaheen; Amal M H Ghanim
Journal:  Exp Biol Med (Maywood)       Date:  2016-01-24

8.  Bone marrow cells ameliorate liver fibrosis and express albumin after transplantation in CCl₄-induced fibrotic liver.

Authors:  Gibran Ali; Muhammad S Masoud
Journal:  Saudi J Gastroenterol       Date:  2012 Jul-Aug       Impact factor: 2.485

9.  Hepatocyte Growth Factor Receptor c-Met Instructs T Cell Cardiotropism and Promotes T Cell Migration to the Heart via Autocrine Chemokine Release.

Authors:  Izabela Komarowska; David Coe; Guosu Wang; Robert Haas; Claudio Mauro; Madhav Kishore; Dianne Cooper; Suchita Nadkarni; Hongmei Fu; Daniel A Steinbruchel; Costantino Pitzalis; Graham Anderson; Pat Bucy; Giovanna Lombardi; Ross Breckenridge; Federica M Marelli-Berg
Journal:  Immunity       Date:  2015-06-09       Impact factor: 31.745

Review 10.  Cell-based and pharmacological neurorestorative therapies for ischemic stroke.

Authors:  Poornima Venkat; Yi Shen; Michael Chopp; Jieli Chen
Journal:  Neuropharmacology       Date:  2017-09-01       Impact factor: 5.250

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.